Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effect of clonidine on PR interval during FESS or rhinoplasty
IRCT20210415050983N10Phase 3Completed
- Sponsor
- Shahid Beheshti University of Medical Sciences
- Start
- Jan 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, open-label, single-arm trial of clonidine, sponsored by Shahid Beheshti University of Medical Sciences. Primary endpoints: PR interval, QT interval and 1 more. Started Jan 2025; status: completed.
02
Drugs
clonidine
Beyond the preview
Go deeper on IRCT20210415050983N10.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20210415050983N10.